Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's Disease
PMID: 38705437
Source: Clin Gastroenterol Hepatol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL